Your browser doesn't support javascript.
loading
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.
Kelly, Ronan J; Draper, Deborah; Chen, Clara C; Robey, Robert W; Figg, William D; Piekarz, Richard L; Chen, Xiaohong; Gardner, Erin R; Balis, Frank M; Venkatesan, Aradhana M; Steinberg, Seth M; Fojo, Tito; Bates, Susan E.
  • Kelly RJ; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Clin Cancer Res ; 17(3): 569-80, 2011 Feb 01.
Article en En | MEDLINE | ID: mdl-21081657

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Quinolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Taxoides / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2011 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Quinolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Taxoides / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2011 Tipo del documento: Article